|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Darya-Varia Laboratoria Tbk, PT
Main Activities: Chemical Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Darya-Varia Laboratoria Tbk, PT Headquarters 8-10/F Talavera Office Park Jln Letjen TB Simatupang; Jakarta; Jakarta; 12430 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : ID1000075708 Financial Auditors: Purwantono, Suherman & Surja (2011) Incorporation Date: February 5, 1976 Total Employees: 1,031 Tel: (62 21) 75924500 |
|
Company Description |
| PT Darya Varia Laboratoria Tbk (DVLA) is a producer of medicines and provider of health care & cosmetic products. DVLA is headquartered in Jakarta, while its manufacturing plant occupies a 41,232 sqm site at Bogor, West Java. DVLA has three main business streams, namely: prescription business, consumer health business (over the counter drugs) and export & Toll manufacturing business. DVLA has two key manufacturing facilities, with a combined land area of 202,000sqm, and floor area of 40,000sqm. | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first three cumulated quarters of 2012, total net operating revenues increased with 24.93%, from IDR 706,266,946 thousands to IDR 882,333,695 thousands. Operating result increased from IDR 108,368,000 thousands to IDR 137,923,232 thousands which means 27.27% change. The results of the period increased 34.06% reaching IDR 108,797,824 thousands at the end of the period against IDR 81,158,224 thousands last year. Return on equity (Net income/Total equity) went from 11.79% to 13.58%, the Return On Asset (Net income / Total Asset) went from 9.28% to 10.14% and the Net Profit Margin (Net Income/Net Sales) went from 11.49% to 12.33% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 33.93% compared to 27.07% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 4.85 to 4.19 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Q3C (cons) |
2012 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
1,073,352,512 |
1,110,425,728 |
| ||
Current Assets |
830,631,360 |
870,602,240 |
| ||
Total Liabilities |
271,917,280 |
334,900,064 |
| ||
Shareholders Equity |
801,435,200 |
775,525,632 |
| ||
Current Liabilities |
198,106,400 |
266,505,168 |
| ||
| * All the accounts are in IDR. | ||
Income Statement
| ||
Total Operating Revenue |
882,333,695 |
628,883,731 |
| ||
Operational Profit (Loss) |
137,923,232 |
108,108,152 |
| ||
Net Profit (Loss) |
108,797,824 |
82,888,224 |
| ||
| * All the accounts are in IDR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
10.14% |
7.46% |
| ||
Annualised Return on Assets (ROA) |
13.52% |
14.92% |
| ||
Return on Equity (ROE) |
13.58% |
10.69% |
| ||
Annualised Return on Equity (ROE) |
18.11% |
21.38% |
| ||
Return on Sales (ROS) |
12.39% |
13.22% |
| ||
Return on Capital |
13.51% |
10.64% |
| ||
Gross Profit Margin |
63.09% |
62.95% |
| ||
Operating Profit Margin |
16.22% |
17.82% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
2.57x |
1.63x |
| ||
Inventory Turnover |
2.11x |
1.62x |
| ||
Current asset turnover |
1.06x |
0.72x |
| ||
Fixed-asset turnover |
3.62x |
2.61x |
| ||
Asset Turnover |
0.82x |
0.56x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
137,923,220 |
108,108,158 |
| ||
EBITDA |
146,537,119 |
113,811,571 |
| ||
Enterprise value |
1,568,619,788 |
1,124,496,934 |
| ||
Enterprise Value / EBITDA |
10.70 |
9.88 |
| ||
Bookvalue (BV) |
1,069,461,012 |
1,106,786,042 |
| ||
Net Cash |
118,765,312 |
57,437,584 |
| Liquidity Ratios | ||
| ||
Current Ratio |
419.29% |
326.67% |
| ||
Quick ratio |
341.81% |
272.81% |
| ||
Doom's day ratio |
159.95% |
121.55% |
| Leverage Ratios | ||
| ||
Leverage ratio |
133.93% |
143.18% |
| ||
Interest Coverage Ratio |
44,253.68% |
56,517.39% |
| ||
Debt to equity |
33.93% |
43.18% |
| ||
Debt to total assets |
25.33% |
30.16% |
| ||
Long Term Debt to Capital |
20.86% |
19.63% |
| ||
Debt / Enterprise Value |
0.25% |
0.32% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
12.84 |
12.69 |
| ||
Price/Book Ratio |
1.76 |
1.31 |
| ||
Market Cap / Net cash |
15.84 |
25.15 |
| Trend Ratios | ||
| ||
Revenue Trend |
125.08% |
135.45% |
| ||
Net Income Trend |
134.06% |
163.56% |
| ||
Operating Income Trend |
127.27% |
150.79% |
| ||
 |